Show/Hide Menu

MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

07. Tue
November

Publication of Third Quarter Interim Statement 2017

08. Mon
January

JP Morgan Healthcare Conference 2018

San Francisco, CA, USA
04. Mon
June

BIO International Convention

Boston, USA

Presentations

09/20/2017
Baader Investment Conference
Munich, Germany
09/18/2017
Berenberg and Goldman Sachs Sixth German Corporate Conference
Muních
09/05/2017
Capital Markets Day Company Update
08/29/2017
Commerzbank Sector Conference
Frankfurt/Main
08/03/2017
Q2 2017 Financial Results
Planegg, Deutschland

Media and investors

Anke Linnartz

Vice President, Head of Corporate Communications and IR

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Alexandra Goller

Senior Manager Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Jochen Orlowski

Associate Director Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact